IMNN Earnings

IMNN reported its earnings on 2026-03-20, showcasing a revenue of against an estimate of , resulting in a 0% surprise. The EPS was 0, surpassing the expected -1.43 by 0%. The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following IMNN's earnings announcement on 2026-03-20, the stock price moved by 0% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, IMNN's stock price tends to shift by an average of 2.29% in the 10 days leading up to earnings and 19.05% in the 10 days following, providing insight into potential market.

For , analysts estimate IMNN's annual revenue to reach undefined, while the EPS is projected at -1.80. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between IMNN's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, IMNN's stock price typically moves by 2.29% in the 10 days before its earnings and 19.05% in the 10 days after. For the upcoming earnings, analysts expect an EPS of -1.80 and revenue of undefined.

The earnings call reflects a mixed sentiment. While there are positive elements like reduced expenses and potential for broader label approval, significant concerns remain. Financial constraints have slowed trial progress, impacting timelines. The company's dependence on partnerships and equity financing poses risks of dilution. Furthermore, competitive pressures and operational risks in trial execution are notable challenges. The Q&A did not alleviate these concerns, as management's responses were often vague. Given these factors, the stock price is likely to remain stable, resulting in a neutral prediction for the next two weeks.